Your Position

HomePage > Product related paper > ctDNA and unknown origin DNA

ctDNA and unknown origin DNA

Papers on ctDNA and unknown origin DNA amplification

2016 May 12;458:138-143. doi: 10.1016/j.cca.2016.05.007. [Epub ahead of print]

Screening for circulating RAS/RAF mutations by multiplex digital PCR.

http://www.ncbi.nlm.nih.gov/pubmed/27181912

Expert Rev Mol Diagn. 2016 May 17:1-5. [Epub ahead of print]

The role of ctDNA detection and the potential of the liquid biopsy for breast cancer monitoring.

http://www.ncbi.nlm.nih.gov/pubmed/27144417

Blood. 2016 Apr 14. pii: blood-2016-03-635219. [Epub ahead of print]

Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma.

http://www.ncbi.nlm.nih.gov/pubmed/27081097

Forensic Sci Int Genet. 2015 Jan;14:194-200. doi: 10.1016/j.fsigen.2014.10.019. Epub 2014 Oct 31.

FACS separation of non-compromised forensically relevant biological mixtures.

http://www.ncbi.nlm.nih.gov/pubmed/25450793

J Forensic Sci. 2014 Jul;59(4):1080-9. doi: 10.1111/1556-4029.12427. Epub 2014 Feb 6.

Swabs as DNA collection devices for sampling different biological materials from different substrates.

http://www.ncbi.nlm.nih.gov/pubmed/24502761

Lung Cancer. 2015 Dec;90(3):509-15. doi: 10.1016/j.lungcan.2015.10.004. Epub 2015 Oct 9.

EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291.

http://www.ncbi.nlm.nih.gov/pubmed/26494259

PLoS One. 2015 Dec 30;10(12):e0145754. doi: 10.1371/journal.pone.0145754. eCollection 2015.

Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers.

http://www.ncbi.nlm.nih.gov/pubmed/26717006

Oncotarget. 2016 Jan 19;7(3):3453-60. doi: 10.18632/oncotarget.6498.

HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer.

http://www.ncbi.nlm.nih.gov/pubmed/26657506

EMBO Mol Med. 2015 May 18;7(8):1034-47. doi: 10.15252/emmm.201404913.

Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease.

http://www.ncbi.nlm.nih.gov/pubmed/25987569

Ralted Articles

Scroll